Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-174P refers to a pseudogene copy of the U6 small nuclear RNA gene, specifically “U6 small nuclear RNA 174, pseudogene.” U6 small nuclear RNA (snRNA) is a highly conserved, functional non-coding RNA component of the spliceosome that is essential for removing introns from eukaryotic pre-mRNA during splicing[1][2]. However, the “pseudogene” designation means RNU6-174P is a non-functional, typically transcriptionally inactive genomic copy derived from the functional U6 gene[3]. Pseudogenes generally do not encode functional molecules and are not known to play direct roles in cellular or disease processes. Multiple U6 snRNA pseudogenes exist in vertebrate genomes as a consequence of evolutionary retrotransposition events[3]. RNU6-174P is not considered a therapeutic target, receptor, enzyme, or functional RNA. Key context: - The functional U6 snRNA is part of the core spliceosome and deeply involved in splicing, but pseudogenes like RNU6-174P do not produce functional RNA[1][2]. - There is nothing therapeutically actionable nor mechanistically interesting directly associated with this pseudogene variant[3]. - Inclusion of "RNA, U6 small nuclear 174, pseudogene" as a drug target is **incorrect**. Summary judgment: - RNU6-174P is a **non-functional, non-target pseudogene** that does not encode a protein or functional RNA and has no known biological function, therapeutic actionability, or disease association.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 174, pseudogene (RNU6-174P).